CPHI - China Pharma Holdings, Inc.

NYSE American - NYSE American Delayed Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201712/31/201612/31/201512/31/2014
Total Revenue13,212.31415,570.51420,351.6322,133.866
Cost of Revenue10,743.76412,352.00418,887.06919,465.706
Gross Profit2,468.553,218.511,464.5612,668.16
Operating Expenses
Research Development90.474365.969961.8972,798.557
Selling General and Administrative5,480.5456,302.4416,191.1985,063.271
Non Recurring----
Others--343.023-1,640.531-1,640.531
Total Operating Expenses17,708.35919,763.8434,546.92658,680.113
Operating Income or Loss-4,496.045-4,193.326-14,195.296-36,546.247
Income from Continuing Operations
Total Other Income/Expenses Net-14,658.889-4,681.123-1,149.783-2,927.471
Earnings Before Interest and Taxes-4,496.045-4,193.326-14,195.296-36,546.247
Interest Expense-539.334-849.557-1,165.164-785.804
Income Before Tax-19,154.934-8,874.449-15,345.079-39,473.718
Income Tax Expense122.631308.17560.43977.042
Minority Interest----
Net Income From Continuing Ops-19,277.565-9,182.624-15,405.518-39,550.76
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-19,277.565-9,182.624-15,405.518-39,550.76
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-19,277.565-9,182.624-15,405.518-39,550.76